Headed to AusBiotech next week? ITR will be attending!
Connect with Marie-Josee Dupuis and Bassem Attalla if you’re looking for a partner to help launch your next preclinical program.

ITR works with pharma and biotech teams to transform early-stage discoveries into clinical-ready candidates. Our capabilities include:
• End-to-end preclinical safety programs spanning in vivo, in vitro, and in silico approaches
• A fully compliant BSL-2 facility supporting specialized and emerging contaminant studies
• Customizable, GLP-aligned study designs built to meet regulatory expectations
• Strategic expertise to help you move confidently from discovery to IND submission

Let’s connect at AusBiotech and explore how ITR can accelerate your development journey.